These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35185351)

  • 1. The Role of AMACR, CD10, TMPRSS2-ERG, and p27 Protein Expression Among Different Gleason Grades of Prostatic Adenocarcinoma on Needle Biopsy.
    Gülhan Ö; Mahi B
    Clin Med Insights Oncol; 2020; 14():1179554920947322. PubMed ID: 35185351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression.
    Warrick JI; Humphrey PA
    Am J Surg Pathol; 2013 Nov; 37(11):1709-14. PubMed ID: 23797726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of immunohistochemical markers alpha methyl acyl coA racemase (AMACR) and Ets related gene (ERG) in prostate cancer.
    Stephen N; Badhe BA
    Int J Clin Exp Pathol; 2022; 15(9):364-372. PubMed ID: 36237639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
    Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
    Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue.
    Andrews C; Humphrey PA
    Am J Surg Pathol; 2014 Jul; 38(7):1007-12. PubMed ID: 24705308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study.
    Sayed RMS; El Shorbagy G; Shibel PEE
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2861-2868. PubMed ID: 37642075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
    Herawi M; Epstein JI
    Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer.
    Box A; Alshalalfa M; Hegazy SA; Donnelly B; Bismar TA
    Tumour Biol; 2016 Sep; 37(9):12287-12299. PubMed ID: 27271990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-associated changes in alpha-methyl CoA racemase (AMACR) expression in nonneoplastic prostatic tissues.
    Gologan A; Bastacky S; McHale T; Yu J; Cai C; Monzon-Bordonaba F; Dhir R
    Am J Surg Pathol; 2005 Nov; 29(11):1435-41. PubMed ID: 16224209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of steroid and peptide hormone receptors, metabolic enzymes and EMT-related genes in prostate tumors in relation to the presence of the TMPRSS2/ERG fusion.
    Gerashchenko GV; Mevs LV; Chashchina LI; Pikul MV; Gryzodub OP; Stakhovsky EO; Kashuba VI
    Exp Oncol; 2018 Jun; 40(2):101-108. PubMed ID: 29949537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study the Expression of CD10 in Prostate Carcinoma and its Correlation with Various Clinicopathological Parameters.
    Singh L; Marwah N; Bhutani N; Pawar D; Kapil R; Sen R
    Iran J Pathol; 2019; 14(2):135-145. PubMed ID: 31528170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is There a Role for Genetic Information in Risk Assessment and Decision Making in Prostate Cancer?
    Nowroozi M; Ayati M; Amini E; Mahdian R; Yousefi B; Arbab A; Jamali Zawarei M; Niroomand H; Ghorbani H; Ghadian A
    Nephrourol Mon; 2016 Nov; 8(6):e41505. PubMed ID: 27933279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diagnostic use of ERG in resolving an "atypical glands suspicious for cancer" diagnosis in prostate biopsies beyond that provided by basal cell and α-methylacyl-CoA-racemase markers.
    Shah RB; Tadros Y; Brummell B; Zhou M
    Hum Pathol; 2013 May; 44(5):786-94. PubMed ID: 23158212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial atrophy on prostate needle biopsy cores: a morphologic and immunohistochemical study.
    Wang W; Sun X; Epstein JI
    Am J Surg Pathol; 2008 Jun; 32(6):851-7. PubMed ID: 18408595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma.
    Boran C; Kandirali E; Yilmaz F; Serin E; Akyol M
    Urol Oncol; 2011; 29(6):614-23. PubMed ID: 20189848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of ERG-antibody in Benign Mimickers of Prostate Cancer.
    Bachurska SY; Staykov DG; Ivanov GP; Belovezhdov VT
    Folia Med (Plovdiv); 2016 Mar; 58(1):48-53. PubMed ID: 27383878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations of PTEN and ERG Immunoexpression in Prostate Carcinoma and Lesions Related to Its Natural History: Clinical Perspectives.
    Voulgari O; Goutas D; Pergaris A; Belogiannis K; Thymara E; Kavantzas N; Lazaris AC
    Curr Issues Mol Biol; 2023 Mar; 45(4):2767-2780. PubMed ID: 37185705
    [No Abstract]   [Full Text] [Related]  

  • 18. Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy.
    Farinola MA; Epstein JI
    Hum Pathol; 2004 Oct; 35(10):1272-8. PubMed ID: 15492996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center.
    Nie L; Pan X; Zhang M; Yin X; Gong J; Chen X; Xu M; Zhou Q; Chen N
    Prostate; 2019 Jun; 79(8):819-825. PubMed ID: 30900303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies.
    Yaskiv O; Zhang X; Simmerman K; Daly T; He H; Falzarano S; Chen L; Magi-Galluzzi C; Zhou M
    Am J Surg Pathol; 2011 Jul; 35(7):1062-8. PubMed ID: 21623182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.